Literature DB >> 15979987

Ovarian stromal blood flow in the prediction of ovarian response during in vitro fertilization treatment.

Ernest Hung Yu Ng1, Oi Shan Tang, Carina Chi Wai Chan, Pak Chung Ho.   

Abstract

BACKGROUND: This study evaluated the role of ovarian stromal blood flow in the prediction of the ovarian response of infertile women by comparing age of women, body mass index (BMI), basal FSH concentration, antral follicle count (AFC) and ovarian stromal blood flow indices measured by power Doppler in two-dimensional ultrasound. Patients were aged <40 years with basal FSH <10 IU/l on recruitment for IVF treatment.
METHODS: All received a standard regimen of ovarian stimulation in their first IVF cycle. AFC, pulsatility index, resistance index and peak systolic blood flow velocity of ovarian stromal vessels were determined on the second day of the treatment cycle prior to ovarian stimulation. Ovarian response was represented by the number of oocytes, serum oestradiol, and the duration and dosage of gonadotrophins.
RESULTS: A total of 136 women were included in the analysis. Basal FSH concentration achieved the best predictive value in relation to the number of oocytes obtained, followed by AFC and BMI. AFC was the only predictive factor of serum oestradiol concentration on the day of HCG while BMI was predictive of the gonadotrophin dosage.
CONCLUSION: Ovarian stromal blood flow indices measured by power Doppler ultrasound had no predictive value for the ovarian response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15979987     DOI: 10.1093/humrep/dei166

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

Review 1.  Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.

Authors:  Megan E B Clowse; Millie A Behera; Carey K Anders; Susannah Copland; Cynthia J Coffman; Phyllis C Leppert; Lori A Bastian
Journal:  J Womens Health (Larchmt)       Date:  2009-03       Impact factor: 2.681

Review 2.  Maintaining the reproductive potential of cancer patients during cancer treatment.

Authors:  Djana Harp; Indrajit Chowdhury; Minerva Garcia-Barrio; Crystal Welch; Roland Matthews; Winston Thompson
Journal:  Front Biosci (Schol Ed)       Date:  2014-01-01

3.  Protective effect of gonadotropin-releasing hormone agonist against chemotherapy-induced ovarian dysfunction: A meta-analysis.

Authors:  Fei Zheng; Bin Zhu; Qingjing Feng; Lili Wu; Yuechong Cui; Yumo Liu; Yingqian Wang
Journal:  Oncol Lett       Date:  2019-04-15       Impact factor: 2.967

Review 4.  GnRH Analogues as a Co-Treatment to Therapy in Women of Reproductive Age with Cancer and Fertility Preservation.

Authors:  Georgios Valsamakis; Konstantinos Valtetsiotis; Evangelia Charmandari; Irene Lambrinoudaki; Nikolaos F Vlahos
Journal:  Int J Mol Sci       Date:  2022-02-18       Impact factor: 5.923

5.  The role of FSH to AMH ratio in poor prognosis patients undergoing ICSI cycle

Authors:  İlay Gözükara; Nafiye Yılmaz; Mehmet Ufuk Ceran; Ece Atalay; İnci Kahyaoğlu; Hacer Cavidan Gülerman; Yaprak Engin-Üstün
Journal:  J Turk Ger Gynecol Assoc       Date:  2022-03-10

6.  Acupuncture for Poor Ovarian Response: A Randomized Controlled Trial.

Authors:  Jihyun Kim; Hoyoung Lee; Tae-Young Choi; Joong Il Kim; Byoung-Kab Kang; Myeong Soo Lee; Jong Kil Joo; Kyu Sup Lee; Sooseong You
Journal:  J Clin Med       Date:  2021-05-18       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.